Tibor Pakozdi

931 total citations · 1 hit paper
7 papers, 638 citations indexed

About

Tibor Pakozdi is a scholar working on Molecular Biology, Oncology and Developmental Biology. According to data from OpenAlex, Tibor Pakozdi has authored 7 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Developmental Biology. Recurrent topics in Tibor Pakozdi's work include Genomics and Chromatin Dynamics (3 papers), Epigenetics and DNA Methylation (2 papers) and Congenital limb and hand anomalies (1 paper). Tibor Pakozdi is often cited by papers focused on Genomics and Chromatin Dynamics (3 papers), Epigenetics and DNA Methylation (2 papers) and Congenital limb and hand anomalies (1 paper). Tibor Pakozdi collaborates with scholars based in United States, Germany and Switzerland. Tibor Pakozdi's co-authors include Yad Ghavi-Helm, Eileen E. M. Furlong, Wolfgang Huber, Felix A. Klein, Lucia Ciglar, Daan Noordermeer, Simon Anders, Jelena Erceg, Adrian P. Bracken and Charles Girardot and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Tibor Pakozdi

7 papers receiving 638 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancer loops appear stable during development and are associated with paused polymerase

2014 383 citations Yad Ghavi-Helm, Felix A. Klein et al. Nature profile →

Peers

Countries citing papers authored by Tibor Pakozdi

Since Specialization

Citations

This map shows the geographic impact of Tibor Pakozdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Pakozdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Pakozdi more than expected).

Fields of papers citing papers by Tibor Pakozdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Pakozdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Pakozdi. The network helps show where Tibor Pakozdi may publish in the future.

Co-authorship network of co-authors of Tibor Pakozdi

This figure shows the co-authorship network connecting the top 25 collaborators of Tibor Pakozdi. A scholar is included among the top collaborators of Tibor Pakozdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tibor Pakozdi. Tibor Pakozdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models 2021 ·Oncotarget ·Lindsay R. Stolzenburg, (unknown), Bridget Riley‐Gillis, Tibor Pakozdi, (unknown), Paul A. Ellis, Julie L. Wilsbacher, Cyril Y. Ramathal	4
2	350 RNA-seq genomic analysis demonstrated the molecular efficacy of Risankizumab in a moderate-to-severe plaque psoriasis phase 2 clinical study 2018 ·Journal of Investigative Dermatology ·Tibor Pakozdi, Robert W. Georgantas, Kristie M. Grebe, (unknown)	4
3	Dual functionality of cis-regulatory elements as developmental enhancers and Polycomb response elements 2017 ·Genes & Development ·Jelena Erceg, Tibor Pakozdi, Raquel Marco-Ferreres, Yad Ghavi-Helm, Charles Girardot, Adrian P. Bracken, Eileen E. M. Furlong	62
4	Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma 2017 ·Proceedings of the National Academy of Sciences ·Artyom A. Alekseyenko, Erica M. Walsh, Barry M. Zee, Tibor Pakozdi, Peter Hsi, Madeleine E. Lemieux, Paola Dal Cin, Tan A. Ince, Peter V. Kharchenko, Mitzi I. Kuroda, Christopher A. French	92
5	FourCSeq: analysis of 4C sequencing data 2015 ·Bioinformatics ·Felix A. Klein, Tibor Pakozdi, Simon Anders, Yad Ghavi-Helm, Eileen E. M. Furlong, Wolfgang Huber	67
6	Enhancer loops appear stable during development and are associated with paused polymerase breakdown → 2014 ·Nature ·Yad Ghavi-Helm, Felix A. Klein, Tibor Pakozdi, Lucia Ciglar, Daan Noordermeer, Wolfgang Huber, Eileen E. M. Furlong	383
7	A Novel Complex, RUNX1-MYEF2, Represses Hematopoietic Genes in Erythroid Cells 2012 ·Molecular and Cellular Biology ·(unknown), Tibor Pakozdi, Rutger W. W. Brouwer, Rui Monteiro, (unknown), Vedran Franke, Jan Christian Bryne, (unknown), (unknown), Wilfred F. J. van IJcken, Charlotte Andrieu‐Soler, Jeroen Demmers, Roger Patient, Éric Soler, Boris Lenhard, Frank Grosveld	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact